Skip to content
Inciteful Med

The Genetic Blueprint: Understanding Subtypes and Inheritance

Last updated:

Glanzmann Thrombasthenia (GT) is an inherited autosomal recessive disorder, meaning a child must receive a gene mutation from both parents to develop the condition. There are three subtypes (Type I, II, and III) based on platelet receptor levels, but subtype does not always predict bleeding severity.

Key Takeaways

  • • Glanzmann Thrombasthenia is an autosomal recessive disorder requiring a gene mutation from both parents.
  • • Carriers typically have no bleeding symptoms despite having fewer platelet receptors.
  • • Type I GT has fewer than 5% of receptors, while Type II has 5-20%.
  • • Type III (Variant) GT has non-functioning receptors and often causes milder bleeding.
  • • Bleeding severity varies widely even among family members with the same specific mutation.

Understanding the genetics of Glanzmann Thrombasthenia (GT) can help explain why it appeared in your family and what to expect for the future. While the diagnosis depends on how the “hooks” (receptors) on your platelets work, the root cause is found in your DNA.

The ‘Two Keys’ Analogy

GT is an autosomal recessive disorder [1][2]. To understand what this means, imagine that to “lock” a blood vessel and stop a bleed, you need two working keys.

  • Parents (Carriers): Each parent usually has one working key (gene) and one broken key [1][3]. Because they have one working key, they can still “lock the door” and stop bleeding normally. They are called carriers [1].
  • The Child (Affected): If a child inherits the broken key from both parents, they have two broken keys and no way to lock the door [1][4]. This is how a child can have GT even if neither parent has a bleeding disorder.

Do Carriers Bleed?

In most cases, carriers (people with only one GT gene mutation) do not have bleeding problems [1][2]. Their platelets typically have about 50% to 60% of the normal number of hooks, which is more than enough to stop bleeding effectively [5][6].

The Three Subtypes of GT

Doctors classify GT into three types based on how many hooks (GPIIb/IIIa receptors) are present on the surface of the platelets.

Subtype Quantity of Hooks Description
Type I <5% The most common form. Hooks are almost entirely missing from the platelet surface [7][8].
Type II 5% – 20% A reduced number of hooks are present, but not enough for normal clotting [7][8].
Type III (Variant) >20% Often a “near normal” number of hooks are present, but they are broken and cannot grab the mortar (fibrinogen) [7][8].

Does the Subtype Predict Bleeding?

It is natural to assume that Type I (nearly no hooks) would be much worse than Type II (some hooks). However, research shows that for Type I and Type II, the severity of bleeding does not always correlate with the subtype [7][9].

  • A person with Type II can sometimes have more frequent or severe bleeds than someone with Type I [7].
  • Even family members with the exact same mutation can have very different bleeding experiences [10].
  • One exception is Type III (Variant): These patients often have significantly fewer severe bleeding episodes compared to those with Type I or II [7].

The Role of Consanguinity

Because GT is so rare, it is much more likely to occur when parents are related by blood (consanguinity), such as being first or second cousins [11][12]. In these cases, both parents are more likely to carry the same “broken key” inherited from a common ancestor [13]. High rates of GT are often found in geographic “hotspots” where these family structures are traditional [14][11]. Recognizing this can help families seek genetic counseling early to understand the risks for future children [13][12].

Frequently Asked Questions

How is Glanzmann Thrombasthenia inherited?
Glanzmann Thrombasthenia is an autosomal recessive disorder. This means a child must inherit a gene mutation from both parents to have the condition. If a person inherits only one mutated gene, they are a carrier and usually do not have symptoms.
Do carriers of Glanzmann Thrombasthenia have symptoms?
In most cases, carriers do not experience bleeding problems. They typically have about 50% to 60% of the normal number of platelet receptors, which is sufficient for the blood to clot normally.
What are the different types of Glanzmann Thrombasthenia?
There are three subtypes based on the number of working receptors (hooks) on platelets. Type I has less than 5% of receptors, Type II has 5-20%, and Type III (Variant) has near-normal numbers but the receptors do not work correctly.
Does the subtype determine how severe the bleeding will be?
Not always. For Type I and Type II, bleeding severity can vary widely, even among family members with the same mutation. However, patients with Type III (Variant) often experience milder bleeding episodes compared to the other types.
Why is family history important in Glanzmann Thrombasthenia?
Because GT is a rare recessive disorder, it is more likely to occur when parents are related by blood (such as cousins). Related parents have a higher chance of carrying the same genetic mutation inherited from a common ancestor.

Questions for Your Doctor

  • • If I am a carrier, do I need to take any precautions before surgery or dental work?
  • • Is my (or my child's) specific mutation classified as 'Type III' (Variant), and does that mean a lower risk of severe bleeding?
  • • Can we test other family members to see if they are carriers for this specific mutation?
  • • Are there other genetic factors, besides GT, that could be making the bleeding symptoms more severe?
  • • Would meeting with a genetic counselor help us understand the risks for future children or other family members?

Questions for You

  • • Are there any family members who have mild bleeding symptoms, like bruising easily or long nosebleeds, even if they haven't been diagnosed with GT?
  • • Are the parents of the child with GT related in any way (such as being cousins)?
  • • How did my doctor determine my subtype (Type I, II, or III), and was it based on flow cytometry or genetic testing?
  • • Have I noticed any difference in bleeding severity between relatives who have the same diagnosis?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Glanzmann thrombasthenia: genetic basis and clinical correlates.

    Botero JP, Lee K, Branchford BR, et al.

    Haematologica 2020; (105(4)):888-894 doi:10.3324/haematol.2018.214239.

    PMID: 32139434
  2. 2

    Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.

    Ramzi M, Dehghani M, Haghighat S, Nejad HH

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):688-690 doi:10.6002/ect.2014.0165.

    PMID: 26134714
  3. 3

    Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

    Mathews N, Rivard GE, Bonnefoy A

    Journal of blood medicine 2021; (12()):449-463 doi:10.2147/JBM.S271744.

    PMID: 34149292
  4. 4

    Glanzmann Thrombasthenia in a Newborn Due to a Rare Homozygous Missense Mutation.

    Faraz S, Nikhat F, Hayel Suleiman Beshtawi H, et al.

    Cureus 2024; (16(12)):e75291 doi:10.7759/cureus.75291.

    PMID: 39776701
  5. 5

    Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.

    Loroch S, Trabold K, Gambaryan S, et al.

    Thrombosis and haemostasis 2017; (117(3)):556-569 doi:10.1160/TH16-07-0515.

    PMID: 28078347
  6. 6

    Novel homozygous frameshift mutation of ITGB3 in the Glanzmann thrombasthenia patient with abnormal bone metabolism and congenital bone defects.

    Luo Y, Guo N, Wang Y, Li J

    Orphanet journal of rare diseases 2025; (20(1)):189 doi:10.1186/s13023-025-03700-9.

    PMID: 40251671
  7. 7

    Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms.

    Mutreja D, Sharma RK, Purohit A, et al.

    The Indian journal of medical research 2017; (145(5)):629-634 doi:10.4103/ijmr.IJMR_718_14.

    PMID: 28948953
  8. 8

    Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center.

    Kasinathan G, Sathar J

    Blood research 2021; (56(4)):315-321 doi:10.5045/br.2021.2021165.

    PMID: 34916340
  9. 9

    Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy.

    Sherief LM, El Ekiaby M, El-Hawy M, et al.

    European journal of pediatrics 2025; (184(5)):318 doi:10.1007/s00431-025-06126-4.

    PMID: 40301132
  10. 10

    Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.

    Ali T, Gul S, Amar A, et al.

    International journal of laboratory hematology 2020; (42(5)):628-635 doi:10.1111/ijlh.13266.

    PMID: 32558238
  11. 11

    Glanzmann Thrombasthenia in Children: Experience From a Tertiary Care Center in Southern India.

    Kongalappa S, Reddy JM, Durugappa T, et al.

    Journal of pediatric hematology/oncology 2019; (41(2)):e68-e71 doi:10.1097/MPH.0000000000001367.

    PMID: 30789846
  12. 12

    Utility of the ISTH bleeding assessment tool (BAT) in diagnosis of Glanzmann Thrombasthenia patients.

    Saqlain N, Fateen T, Tufail H, Mazher N

    Pakistan journal of medical sciences 2022; (38(4Part-II)):791-795 doi:10.12669/pjms.38.4.5361.

    PMID: 35634602
  13. 13

    Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.

    Aloui C, Chakroun T, Granados V, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(8)):689-696 doi:10.1097/MBC.0000000000000779.

    PMID: 30325339
  14. 14

    Gastrointestinal Bleeding/Angiodysplasia in Patients With Glanzmann Thrombasthenia.

    Tarawah RA, Tarawah AM

    Journal of medical cases 2024; (15(12)):401-405 doi:10.14740/jmc4340.

    PMID: 39610914

This guide explains the genetics of Glanzmann Thrombasthenia for educational purposes. Consult a genetic counselor or hematologist for personal risk assessment and medical advice.

Stay up to date

Get notified when new research about Glanzmann Thrombasthenia is published.

No spam. Unsubscribe anytime.